MXPA05007888A - Coagulante autologo y homologo producido a partir de sangre entera anticoagulada. - Google Patents
Coagulante autologo y homologo producido a partir de sangre entera anticoagulada.Info
- Publication number
- MXPA05007888A MXPA05007888A MXPA05007888A MXPA05007888A MXPA05007888A MX PA05007888 A MXPA05007888 A MX PA05007888A MX PA05007888 A MXPA05007888 A MX PA05007888A MX PA05007888 A MXPA05007888 A MX PA05007888A MX PA05007888 A MXPA05007888 A MX PA05007888A
- Authority
- MX
- Mexico
- Prior art keywords
- autologous
- whole blood
- homologous
- anticoagulated whole
- homologous coagulant
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Ecology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
Abstract
Se describe un metodo para la preparacion de un coagulante autologo u homologo estable a partir de sangre entera. La precipitacion directa de sangre entera anticoagulada hacia obvia la necesidad para una etapa de aislamiento de plasma con resultados inesperados. El coagulante autologo y homologo producido por el metodo de la presente invencion demuestra tiempos de coagulacion equivalentes a preparaciones de trombina humana y trombina de bovino disponibles comercialmente, con cineticas mejoradas de liberacion del factor de crecimiento a partir de plaquetas activadas sobre preparaciones de trombina de bovino.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44297403P | 2003-01-27 | 2003-01-27 | |
| PCT/US2004/002191 WO2004068109A2 (en) | 2003-01-27 | 2004-01-27 | Autologous or homologous coagulant produced from anticoagulated whole blood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05007888A true MXPA05007888A (es) | 2005-12-15 |
Family
ID=32825282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05007888A MXPA05007888A (es) | 2003-01-27 | 2004-01-27 | Coagulante autologo y homologo producido a partir de sangre entera anticoagulada. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040208786A1 (es) |
| EP (1) | EP1599715A2 (es) |
| JP (1) | JP2006516630A (es) |
| KR (1) | KR20050105184A (es) |
| CN (2) | CN101317855A (es) |
| AU (1) | AU2004207261B2 (es) |
| BR (1) | BRPI0406931A (es) |
| CA (1) | CA2514001A1 (es) |
| IL (1) | IL169792A0 (es) |
| MX (1) | MXPA05007888A (es) |
| WO (1) | WO2004068109A2 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060094865A1 (en) * | 2004-10-29 | 2006-05-04 | Kapur Terri A | Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions |
| RU2009141918A (ru) * | 2007-04-18 | 2011-05-27 | H2Q Уотер Индастриз Лтд. (Il) | Фильтровальная среда |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| EP2806914B1 (en) | 2012-01-23 | 2021-09-22 | Estar Technologies Ltd | A system and method for obtaining a cellular sample enriched with defined cells such as platelet rich plasma(prp) |
| CA2868862C (en) * | 2012-09-25 | 2017-06-27 | Stem Cell Partners Llc | Method and apparatus for preparing single donor thrombin serum |
| EP3068867B1 (en) | 2013-11-16 | 2018-04-18 | Terumo BCT, Inc. | Expanding cells in a bioreactor |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| CA3046406C (en) * | 2017-02-09 | 2024-01-30 | Csl Behring Gmbh | A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| WO2018184028A2 (en) | 2017-03-31 | 2018-10-04 | Terumo Bct, Inc. | Cell expansion |
| CA3127191A1 (en) | 2019-01-21 | 2020-07-30 | Eclipse Medcorp, Llc | Methods, systems and apparatus for separating components of a biological sample |
| CN110361531B (zh) * | 2019-08-02 | 2023-04-11 | 天津医科大学总医院 | 一种检测微粒促凝活性的实验方法 |
| CA3159372A1 (en) | 2019-10-31 | 2021-05-06 | Eclipse Medcorp, Llc | Systems, methods and apparatus for separating components of a sample |
| CN112841171A (zh) * | 2021-01-12 | 2021-05-28 | 广州鸿泉生物科技有限公司 | 用于血栓试验中的抗凝猪血、猪血浆的制备方法及应用 |
| JP2024511064A (ja) | 2021-03-23 | 2024-03-12 | テルモ ビーシーティー、インコーポレーテッド | 細胞捕獲及び増殖 |
| JP2023047560A (ja) * | 2021-09-27 | 2023-04-06 | 国立大学法人 東京大学 | 細胞培養用成分、細胞培養用培地、血清の製造方法、及び、細胞の製造方法 |
| CN115825263A (zh) * | 2022-11-04 | 2023-03-21 | 南京科技职业学院 | 一种血清中氧化型白蛋白的检测方法及其试剂盒 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4359463A (en) * | 1980-11-26 | 1982-11-16 | Rock Gail A | Stabilization of Factor VIII activity in whole blood or blood plasma |
| DE3366540D1 (en) * | 1982-04-28 | 1986-11-06 | Trustees Of The Garfield Westo | Processes for the production of blood products |
| US4675385A (en) * | 1985-03-27 | 1987-06-23 | Alpha Therapeutic Corporation | Isolation of human plasma procoagulant protein factor VIII from biological factors |
| JPS6360931A (ja) * | 1986-08-29 | 1988-03-17 | Noboru Sato | 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法 |
| US5135875A (en) * | 1990-08-15 | 1992-08-04 | Abbott Laboratories | Protein precipitation reagent |
| SE9403833D0 (sv) * | 1994-11-08 | 1994-11-08 | Global Hemostasis Inst Mgr Ab | Analysförfarande och kit |
| US5510102A (en) * | 1995-01-23 | 1996-04-23 | The Regents Of The University Of California | Plasma and polymer containing surgical hemostatic adhesives |
| US6320029B1 (en) * | 1996-11-29 | 2001-11-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
| CA2257791A1 (en) * | 1996-05-24 | 1997-11-27 | Thermogenesis Corp. | Fibrinogen apparatus, method and container |
| US5783447A (en) * | 1996-10-02 | 1998-07-21 | University Of Medicine And Dentistry Of New Jersey | Hypercoagulability comparative determinants obtained using detection systems with variable force-induced energy inputs |
| US5783093A (en) * | 1997-01-02 | 1998-07-21 | Haemonetics Corporation | Blood cell concentrates using a single solution for anticoagulation and preservation |
| US6274090B1 (en) * | 1998-08-05 | 2001-08-14 | Thermogenesis Corp. | Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| US6472162B1 (en) * | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
| KR100880622B1 (ko) * | 2000-06-29 | 2009-01-30 | 바이오신텍 캐나다 인코포레이티드 | 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법 |
| EP1459724B1 (en) * | 2001-12-28 | 2013-11-20 | Terumo Kabushiki Kaisha | Blood bag system and method of inactivating pathogenic microorganisms |
| US20040120942A1 (en) * | 2002-12-23 | 2004-06-24 | Mcginnis Daniel | Device and process for the preparation of autologous thrombin serum |
-
2004
- 2004-01-27 MX MXPA05007888A patent/MXPA05007888A/es active IP Right Grant
- 2004-01-27 AU AU2004207261A patent/AU2004207261B2/en not_active Ceased
- 2004-01-27 JP JP2006503054A patent/JP2006516630A/ja active Pending
- 2004-01-27 US US10/765,694 patent/US20040208786A1/en not_active Abandoned
- 2004-01-27 BR BR0406931-5A patent/BRPI0406931A/pt not_active IP Right Cessation
- 2004-01-27 CA CA002514001A patent/CA2514001A1/en not_active Abandoned
- 2004-01-27 EP EP04705602A patent/EP1599715A2/en not_active Withdrawn
- 2004-01-27 KR KR1020057013816A patent/KR20050105184A/ko not_active Application Discontinuation
- 2004-01-27 CN CNA2008101304992A patent/CN101317855A/zh active Pending
- 2004-01-27 CN CNB2004800083526A patent/CN100415093C/zh not_active Expired - Fee Related
- 2004-01-27 WO PCT/US2004/002191 patent/WO2004068109A2/en active Application Filing
-
2005
- 2005-07-20 IL IL169792A patent/IL169792A0/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004207261B2 (en) | 2009-07-09 |
| WO2004068109A3 (en) | 2005-10-27 |
| IL169792A0 (en) | 2007-07-04 |
| EP1599715A2 (en) | 2005-11-30 |
| JP2006516630A (ja) | 2006-07-06 |
| CN101317855A (zh) | 2008-12-10 |
| CN1764372A (zh) | 2006-04-26 |
| KR20050105184A (ko) | 2005-11-03 |
| CN100415093C (zh) | 2008-09-03 |
| AU2004207261A1 (en) | 2004-08-12 |
| US20040208786A1 (en) | 2004-10-21 |
| CA2514001A1 (en) | 2004-08-12 |
| BRPI0406931A (pt) | 2006-01-03 |
| WO2004068109A2 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05007888A (es) | Coagulante autologo y homologo producido a partir de sangre entera anticoagulada. | |
| WO2004084825A3 (en) | Wound healing composition derived from low platelet concentration plasma | |
| AU5439400A (en) | Autologous thrombin | |
| CA2113660C (en) | Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out | |
| Mazzucco et al. | Platelet‐rich plasma and platelet gel preparation using Plateltex® | |
| ATE413182T1 (de) | Gerät und verfahren zur herstellung von stabilem langzeitigem thrombin aus plasma sowie so hergestelltes thrombin | |
| Hellstern et al. | Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy | |
| WO2004094475A3 (en) | Tissue factor antibodies and uses thereof | |
| EP2520316B1 (en) | Thrombin isolated from blood and blood fractions | |
| CA2761603C (en) | Method for the preparation of at least one compound from blood, and extraction device for use in the execution of said method | |
| TW200606177A (en) | Glycoprotein VI antibodies and methods thereof | |
| DE60317561D1 (de) | Vorrichtung und verfahren zur herstellung von autologem thrombinserum | |
| WO2003020889A3 (en) | Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules | |
| WO2004022696A3 (en) | Fibrin cell supports and methods of use thereof | |
| IL158082A0 (en) | Amlodipine camsylate and methods for the preparation thereof | |
| WO1997041206A2 (en) | Von willebrand factor multimerase | |
| Munro et al. | Sustained bleeding after a leech bite in the apparent absence of hirudin | |
| KR102085157B1 (ko) | 단일 헌혈자 트롬빈 혈청의 제조방법 및 장치 | |
| WO2003047650A3 (en) | Preparation of red blood cells having reduced immunogenicity | |
| Assafim et al. | Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom | |
| WO2006008267A3 (en) | Methods for optimizing forming viiia-based hemostatic treatment | |
| ATE442434T1 (de) | Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate | |
| Sidelmann et al. | Influence of plasma platelets on activated protein C resistance assay | |
| WO2004050848A3 (en) | Methods for antigen masking of red blood cells resulting in reduced hemolysis | |
| MY160857A (en) | A cancer vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |